Compare Indika Energy Tbk. (INDY) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indika Energy Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indika Energy Tbk. trades at Rp2,830 (market cap 15.01T, 27.38M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indika Energy Tbk. is far larger — about 143.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INDY | SCPI | |
|---|---|---|
Market Cap | 15.01T | 104.4B |
Volume | 27.38M | — |
Lot | 273.78K | — |
Turnover | 77.42B | — |
Average Price | 2,828.02 | — |
Value | 77.42B | — |
Indicative Equilibrium Price | 2,830 | — |
Indicative Equilibrium Volume | 11.12K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indika Energy Tbk.
Indika Energy, PT (the company) was established under its original name of Dipta Diwangkara on Oct 19, 2000 then changed to PT Indika Energy based on Notaries Deed dated Aug 13, 2004.The Company’s articles of association has been amended several times, most recently by notarial deed No. 115 of Sutjipto, S.H., dated Feb 25, 2008, concerning among others, the change in par value, the Company’s name, and public offering.
Read more on INDY →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
